Participants: what method, if any, do you use for monitoring Plavix? The ones I know about are light transmittance aggregometry using ADP as the agonist, impedance aggregometry with ADP, INNOVANCE PFA-100 P2Y ( RUO), Accumetrics Integra VerifyNow P2Y12, the Multiplate analyzer (RUO), or the thromboelastograph (TEG). If you are using one of the point of […]

The Heart has provided a comprehensive history of clopidogrel, whose patent expired yesterday, a milestone in cardiac care that significantly improved myocardial infarct patient survival. We will soon be seeing generic forms of clopidogrel and new antiplatelet drugs. Geo.

This is a February 18, 2014 follow-up from the individual whom I responded to in a January 30 post entitled Clopidogrel Efficacy. I had collaborated with Prof. Bernadette Rodak of Indiana University on the original email to the questioner. Here is the comment (with identification removed): “I would like to thank you and Prof. Rodak for your response […]

Frequent contributor Dave McGlasson and I assisted with this January 11 Advance for Administrators of the Laboratory Karen Appold article entitled New Antiplatelet Drugs Bring Benefits. You may find the discussion helpful. The article requires one minor edit when reading, the glycoprotein IIb/IIIa inhibitors are described as “injectable,” they are actually administered intravenously. I hope you enjoy the article. Geo.